Diabetic retinopathy, oxidative stress and antioxidants

Current Topics in Nutraceutical Research

Volumn 3, Issue 4, 2005, Pages 209-218

  Kowluru, Renu A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Antioxidants; Apoptosis; Capillary cells; Diabetes; Oxidative stress; Retinopathy

Indexed keywords

ACETYLCYSTEINE; ALDOSE REDUCTASE INHIBITOR; ALPHA TOCOPHEROL; AMINOGUANIDINE; ANTIOXIDANT; ASCORBIC ACID; BENFOTIAMINE; BETA CAROTENE; DOBESILATE CALCIUM; GLUCOSE; GREEN TEA EXTRACT; GUANINE NUCLEOTIDE BINDING PROTEIN; NICANARTINE; POLYOL; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; REACTIVE OXYGEN METABOLITE; SELENIUM DERIVATIVE; SELENOPROTEIN; THIOCTIC ACID; TROLOX C; VASCULOTROPIN; ZINC DERIVATIVE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BEHAVIOR MODIFICATION; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; DRUG TARGETING; ENDOTHELIUM CELL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; LASER COAGULATION; METABOLIC REGULATION; MITOCHONDRIAL RESPIRATION; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN TARGETING; RETINA CAPILLARY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; VITRECTOMY;

ANIMALIA;

EID: 32044446735     PISSN: 15407535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Aiello LP. (1997) Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Research 29, 354-362.
2. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. (1998) Diabetic retinopathy. Diabetes Care 21, 143-156.
3. Aiello LM. (2003) Perspectives on diabetic retinopathy. American Journal of Ophthalmology 136, 122-135.
4. Agardh C-D, Stenram U, Torffvit O, Agardh E. (2002) Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. Journal of Diabetes Complications 16, 395-400.
5. Ansari NH, Zhang W, Fulep E, Mansour A. (1998) Prevention of pericyte loss by Trolox in diabetic rat retina. Journal of Toxicology and Environmental Health 24, 467-475.
6. Anuradha CD, Kanno S, Hirano S. (2001) Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluoride-induced apoptosis in HL-60 cells. Free Radical Biology and Medicine 31, 367-373.
7. Armstrong D, Abdella N, Salman A, Miller N, Rahman EA, Bojancyzk M. (1992) Relationship of lipid peroxides to diabetic complications. Journal of Diabetes and Complications 6, 116-122.
8. Atluri H, Anand BS, Patel J, Mitra AK. (2004) Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration. Experimental Eye research 78, 815-822.
9. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. Journal of Clinical Investigations 102, 783-791.
10. Barber AJ. (2003) A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Progress in NeuroPsychpharmacology and Biological Psuchiatry 27, 283-290
11. Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. (1995) High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44, 1323-1327.
12. Baynes JW. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
13. Baynes JW, Thrope SR. (1999) Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48, 1-9.
14. Brownlee M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
15. Bursell SE, Clermont AC, Aiello LP, Aiello LM, Schlossman DK, Feener EP, Laffel L, King GL (1999) High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care 22, 1245-1251.
16. Cai L, Kang YJ. (2001) Oxidative stress and diabetic cardiomyopathy: a brief review. Cardiovascular Toxicology 1, 181-193.
17. Carmo, A, Cunha-Vaz JG, Carvalho AP, Lopes MC. (1999) L-arginine transport in retinas from streptozotocin diabetic rats: correlation with the level of IL-1 beta and NO synthase activity. Vision Research 39, 3817-3823.
18. Chang CK, LoCicero J. (2004) Overexpressed nuclear factor [kappa]B correlates with enhanced expression of interleukin-1[beta] and inducible nitric oxide synthase in aged murine lungs to endotoxic stress. The Annals of Thoracic Surgery 77, 1222-1227.
19. Comer GM, Ciulla TA. (2005) Current and future pharmacological intervention for diabetic retinopathy. Expert Opinion on Emerging Drugs 10, 441-455.
20. Curcio F, Ceriello A. (1992) Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants:new insights on the pathophysiological mechanism of diabetic vascular complications. In Vitro Cell and Developmental Biology 28, 787-790.
21. Diabetes Control and ComplicationsTrial Research Group. (1993) The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329, 977-986.
22. Diabetes Control and Complications Trial Research Group. (1997) Hypoglycemia in the diabetes control and complications trial. Diabetes 46, 271-286.
23. Diabetes Control and Complications Trial Research Group. (1998) Early worsening of diabetic retinopathy in the diabetes control and complication trial. Archives of Ophthalmology 116, 874-886.
24. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. (2002) Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. Journal of Medical Association 287, 2563-2569.
25. Du Y, Smith MA, Miller CM, Kern TS. (2002) Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. Journal of Neurochemistry 80, 771-779.
26. Du Y, Miller CM, Kern TS. (2003) Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radical Biology and Medicine 35, 1491-1499.
27. Engerman RL, Davis MD, Bloodworth JMB, Jr. (1971) Retinopathy in experimental diabetes: its relevance to diabetic retinopathy in man. In: Rodriguez R, Vallance-Owen J, (Eds). Diabetes, Proceedings of the VII Congress of International Diabetes Federation (Amsterdam: Excerpta Medica), pp. 261-267.
28. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. (2003) Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 52, 1-8.
29. Frank RN. (2004) Diabetic retinopathy. New England Journal of Medicine 350, 45-48
30. Halliwell B. (1997) What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Letters 411, 157-160.
31. Hammes HP, Bartmann A, Engel L, Wulfroth P. (1997) Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia 40, 629-634.
32. Hammes HP. (2003) Pathophysiological mechanisms of diabetic angiopathy. J Diabetes Complications 17, 16-19.
33. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. (2003) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Medicine 9, 294-299
34. Hancock JT, Desikan R, Neill SJ. (2001) Does the redox status of cytochrome C act as a fail-safe mechanism in the regulation of programmed cell death. Free Radical Biology and Medicine 31, 697-703.
35. Haskins K, Bradley B, Powers K, Fadok V, Flores S, Ling X, Reusch J, Kench J. (2003) Oxidative stress in Type 1 diabetes. Annals of the New York Academy of Sciences 1005, 43-54.
36. Heath H, Rutter AC, Beck TC. (1962) Changes in the ascorbic acid and glutathione content of the retina and adrenals from alloxan-diabetic rats. Vision Research 2, 431-437.
37. Hinokio Y, Suzuki S, Hirai M, Suzuki C, Suzuki M, Toyota T. (2002) Urinary excretion of 8-oxo-7, 8-dihydro-2′-deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 45, 877-882.
38. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. American Journal of Pathology 158, 147-152.
39. Kern TS, Kowluru R, Engerman RL. (1995) Questions raised by study of experimental diabetic retinopathy. In: Kaneko S Baba T (Eds), Diabetes 1994; Proceedings of the 15th International Diabetes Federation Congress (Kobe, Japan: Excerpta Medica) pp. 331-334.
40. Kern TS, Tang J, Mizutani M, Kowluru R, Nagraj R, Lorenzi M. (2000) Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia. Investigative Ophthalmology and Visual Science 41, 3972-3978.
41. Kern TS, Engerman RL. (2001) Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. Diabetes 50, 1636-1642.
42. Knudsen CA, Tappel AL, North JA. (1996) Multiple antioxidants protect against heme protein and lipid oxidation in kidney tissue. Free Radical Biology and Medicine 20, 165-173.
43. Kowluru RA, Kern TS, Engerman RL. (1996) Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radical Biology and Medicine 22, 587-592.
44. Kowluru RA, Jirousek MR, Stramm LE, Farid NA, Engerman RL, Kern TS. (1998) Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes 47, 464-469.
45. Kowluru RA, Engerman RL, Kern TS. (2000) Abnormalities of retinal metabolism in diabetes or experimental galactosemia VIII. Prevention by aminoguanidine. Current Eye Research 21, 814-819.
46. Kowluru RA. (2001) Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are interrelated. Acta Diabetologica 38, 179-185.
47. Kowluru RA, Tang J, Kern TS. (2001) Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 50, 1938-1942.
48. Kowluru RA, Koppolu P. (2002) Diabetes-induced activation of Caspase-3 in retina: Effect of antioxidant therapy. Free Radical Research 36, 993-999.
49. Kowluru RA. (2003) Effect of re-institution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52, 818-823.
50. Kowluru RA, Abbas SN. (2003) Diabetes-induced mitochondrial dysfunction in the retina. Investigative Ophthalmology and Visual Science 44, 5327-5334.
51. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. (2003) Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radical Research 37, 1169-1180.
52. Kowluru RA, Odenbach S. (2004a) Effect of long-term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes 53, 3233-3238.
53. Kowluru RA, Odenbach S. (2004b) Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Investigative Ophthalmology and Visual Science 45, 4161-4166.
54. Kowluru RA, Chakrabarti S, Chen S. (2004a) Re-Institution of good metabolic control in diabetic rats on the activation of caspase-3 and nuclear transcriptional factor (NF-kB) in the retina. Acta Diabetologica 44, 194-199.
55. Kowluru RA, Kowluru A, Chakrabarti S, Khan Z. (2004b) Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes 53, 775-783.
56. Kowluru RA, Odenbach S, Basak S. (2005) Lipoic acid inhibits retinal histopathology in diabetic rats via regulating mitochondrial superoxides. Diabetes 54, 222A (Abstract).
57. Li W, Yanoff M, Jian B, He Z. (1999) Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cellular Molecular Biology (Noisy-le-grand) 45, 59-66.
58. Li JM, Shah AM. (2004) Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 287, 1014-1030.
59. Matsura T, Kai M, Fujii Y, Ito H, Yamada K. (1999) Hydrogen peroxide-induced apoptosis in HL-60 cells requires caspase-3 activation. Free Radical Research 30, 73-83.
60. Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, Hamman RF. (1998) Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology 105, 2264-70.
61. McCarty MF. (2005) The putative therapeutic value of high-dose selenium in proliferative retinopathies may reflect down-regulation of VEGF production by the hypoxic retina. Medical Hypotheses 64, 159-161.
62. McCord JM, Edeas M. (2005) SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomedicine and Pharmacotherapy 59, 139-142.
63. Millen AE, Gruber M, Klein R, Klein BE, Palta M, Mares JA. (2003) Relations of serum ascorbic acid and alphatocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology 158, 225-233.
64. Millen AE, Klein R, Folsom AR, Stevens J, Palta M, Mares JA. (2004) Relation between intake of vitamins C and E and risk of diabetic retinopathy in the Atherosclerosis Risk in Communities Study. American Journal of Clinical Nutrition 79, 865-873.
65. Mizutani M, Kern TS, Lorenzi M. (1996) Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. Journal of Clinical Investigation 97, 2883-2890.
66. Mohr S, Xi X, Tang J, Kern TS. (2002) Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51, 1172-1179.
67. Moustafa SA. (2004) Zinc might protect oxidative changes in the retina and pancreas at the early stage of diabetic rats. Toxicology and Applied Pharmacology 201, 149-155.
68. Murata T, Nishida T, Eto S, Mukai N. (1981) Lipid peroxidation in diabetic rat retina. Metabolism and Pediatric Ophthalmology 5, 83-87.
69. Mustata GT, Rosca M, Biemel KM, Reihl O, Smith MA, Viswanathan A, Strauch C, Tang J, Kern TS, Lederer MO, Brownlee M, Weiss MF, Monnier VM. (2005) Pradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes 54, 517-526.
70. Nishimura C, Kuriyama K. (1985) Alteration of lipid peroxide and endogenous antioxidant contents in retina of streptozotocin-induced diabetic rats; effect of vitamin A administration. Japan Journal of Pharmacology 37, 365-372.
71. Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J. (2003) Early oxidative stress in the diabetic kidney: effect of DL-[alpha]-lipoic acid. Free Radical Biology and Medicine 34, 186-195.
72. Pani G, Colavitti R, Bedogni B, Fusco S, Ferraro D, Borrello S, Galeotti T. (2004) Mitochondrial superoxide dismutase: a promising target for new anticancer therapies. Current Medicinal Chemistry 11, 1299-1308.
73. Pollack M, Phaneuf S, Dirks A, Leeuwenburgh C. (2002) The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Annals of the New York Academy of Sciences 959, 93-107.
74. Price DL, Rhett PM, Thorpe SR, Baynes JW. (2001) Chelating activity of advanced glycation end-product inhibitors. Journal of Biological Chemistry 276, 48967-48972.
75. Radi R, Cassina A, Hodara R. (2002) Nitric oxide and peroxynitrite interactions with mitochondria. Biological Chemistry 383, 401-409.
76. Robinson WG, Laver NM, Jacot JL, Glover JP. (1995) Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model. Investigative ophthalmology and Visual Science 36, 2368-2380
77. Robison WG, Jacot JL, Katz ML, Glover JP. (2000) Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. Journal of Ocular Pharmacology and Therapy 16, 109-120.
78. Rota R, Chiavaroli C, Garay RP, Hannaert P. (2004) Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats. European Journal of Pharmacology 495, 217-224
79. Russell JW, Golovoy D, Vincet A, Mahendru P, Olzmann JA, Mentzer A, Feldman EL. (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. The FASEB Journal 16, 1738-1748.
80. Sato S, Secchi EF, Lizak MJ, Fukase S, Ohta N, Murata M, Tasai JF, Kador PF. (1999) Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells. Investigative Ophthalmology and Visual Science 40, 697-704.
81. Sennlaub F, Courtois Y, Goureau O. (2002) Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy. Journal of Neuroscience 22, 3987-3993.
82. Siemianowicz K, Gminski J, Telega A, Wojcik A, Posielezna B, Grabowska-Bochenek R, Francuz T. (2004) Blood antioxidant parameters in patients with diabetic retinopathy. International Journal of Molecular Medicine 14, 433-467.
83. Stitt AW. (2003) The role of advanced glycation in the pathogenesis of diabetic retinopathy. Experimental and Molecular Pathology 75, 95-108.
84. Tesfamariam B, Cohen RA. (1992) Free radicals mediate endothelial dysfunction caused by elevated glucose. American Journal of Physiology 263, H321-H326.
85. Vassilakopoulos T, Karatza M-H, Katsaounou P, Kollintza A, Zakynthinos S, Roussos C. (2003) Antioxidants attenuate the plasma cytokine response to exercise in humans. Journal of Applied Physiology 94, 1025-1032.
86. Verzola D, Bertolotto MB, Villaggio B, Ottonello L, Dallegri F, Frumento G, Berruti Y, Gandolfo MT, Garibotto G, Deferran G. (2002) Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells. Journal of Investigative Medicine 50, 443-451.
87. Vincent AM, Russell JW, Low P, Feldman EL. (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocrine Reviews 25, 612-628.
88. Way KJ, Katai N, King GL. (2001) Protein kinase C and the development of diabetic vascular complications. Diabetes Medicine 18, 945-959.
89. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. (1994) Characterization of the mechanism for the chronic activation of DAG-PKC pathway in diabetes and hypergalactosemia. Diabetes 43, 1122-1129.
90. Yuuki T, Kanda T, Kimura Y, Kotajima N, Tamura J, Kobayashi I, Kishi S. (2001) Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. Journal of Diabetes Complications 15, 257-259.